These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4116579)

  • 1. Immunoprophylaxis and immunotherapy of leukaemia with B.C.G.
    Finklestein JZ; Tittle KL; Imagawa DT
    Lancet; 1972 Oct; 2(7782):875-6. PubMed ID: 4116579
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of spontaneous leukemia in germfree AKR.
    Pollard M; Sharon N
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1494-7. PubMed ID: 5138479
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].
    Lamensans A; Mollier MF; Laurent M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):871-6. PubMed ID: 4885127
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG.
    Mardiney MR; Ungaro PC; Drake WP
    Natl Cancer Inst Monogr; 1973 Dec; 39():89-90. PubMed ID: 4595329
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of drug therapy against a histologically defined rat leukemia.
    Pearson JW; Chaparas SD; Torgersen JA; Perk K; Chirigos MA; Sher NA
    Cancer Res; 1974 Feb; 34(2):355-61. PubMed ID: 4589956
    [No Abstract]   [Full Text] [Related]  

  • 7. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cyclophosphamide (NSC-26271) immunosuppression by bacillus Calmette-Guérin.
    Houchens DP; Gaston MR; Kinney Y; Goldin A
    Cancer Chemother Rep; 1974; 58(6):931-3. PubMed ID: 4614900
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 10. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 11. An experimental model of active immunotherapy preceded by cytoreductive chemotherapy.
    Amiel JL; Berardet M
    Eur J Cancer (1965); 1970 Dec; 6(6):557-9. PubMed ID: 4926872
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-leukaemic AkR mice are not tolerant to cells of leukaemia induced by Gross virus.
    Doré JF; Ajuria E; Mathé G
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):81-4. PubMed ID: 5442690
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological approaches of leukaemia treatment.
    Mathé G
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):855-81. PubMed ID: 4559238
    [No Abstract]   [Full Text] [Related]  

  • 18. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G; Halle-Pannenko O; Bourut C
    Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
    [No Abstract]   [Full Text] [Related]  

  • 19. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D; Mathé G
    Br J Cancer; 1976 May; 33(5):567-70. PubMed ID: 776199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.